List of Tables
Table 1. Drugs for Treating Mental Disorders Market Trends
Table 2. Drugs for Treating Mental Disorders Market Drivers & Opportunity
Table 3. Drugs for Treating Mental Disorders Market Challenges
Table 4. Drugs for Treating Mental Disorders Market Restraints
Table 5. Global Drugs for Treating Mental Disorders Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Drugs for Treating Mental Disorders Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Drugs for Treating Mental Disorders Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Drugs for Treating Mental Disorders Product Type
Table 9. Key Companies Time to Begin Mass Production of Drugs for Treating Mental Disorders
Table 10. Global Drugs for Treating Mental Disorders Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Treating Mental Disorders as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Drugs for Treating Mental Disorders Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Drugs for Treating Mental Disorders Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Drugs for Treating Mental Disorders Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Drugs for Treating Mental Disorders Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Drugs for Treating Mental Disorders Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Drugs for Treating Mental Disorders Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Drugs for Treating Mental Disorders Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Drugs for Treating Mental Disorders Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Drugs for Treating Mental Disorders Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Drugs for Treating Mental Disorders Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Drugs for Treating Mental Disorders Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Drugs for Treating Mental Disorders Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Drugs for Treating Mental Disorders Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Drugs for Treating Mental Disorders Sales Value by Region (2019-2024) & (%)
Table 27. Global Drugs for Treating Mental Disorders Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Drugs for Treating Mental Disorders Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Drugs for Treating Mental Disorders Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Drugs for Treating Mental Disorders Sales Value, (2025-2030) & (US$ Million)
Table 31. Johnson and Johnson Basic Information List
Table 32. Johnson and Johnson Description and Business Overview
Table 33. Johnson and Johnson Drugs for Treating Mental Disorders Products, Services and Solutions
Table 34. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Johnson and Johnson (2019-2024)
Table 35. Johnson and Johnson Recent Developments
Table 36. Pfizer Basic Information List
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Drugs for Treating Mental Disorders Products, Services and Solutions
Table 39. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Pfizer (2019-2024)
Table 40. Pfizer Recent Developments
Table 41. Eli Lilly Basic Information List
Table 42. Eli Lilly Description and Business Overview
Table 43. Eli Lilly Drugs for Treating Mental Disorders Products, Services and Solutions
Table 44. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Eli Lilly (2019-2024)
Table 45. Eli Lilly Recent Developments
Table 46. GlaxoSmithKline Basic Information List
Table 47. GlaxoSmithKline Description and Business Overview
Table 48. GlaxoSmithKline Drugs for Treating Mental Disorders Products, Services and Solutions
Table 49. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of GlaxoSmithKline (2019-2024)
Table 50. GlaxoSmithKline Recent Developments
Table 51. AstraZeneca Basic Information List
Table 52. AstraZeneca Description and Business Overview
Table 53. AstraZeneca Drugs for Treating Mental Disorders Products, Services and Solutions
Table 54. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of AstraZeneca (2019-2024)
Table 55. AstraZeneca Recent Developments
Table 56. Bristol-Myers Squibb Basic Information List
Table 57. Bristol-Myers Squibb Description and Business Overview
Table 58. Bristol-Myers Squibb Drugs for Treating Mental Disorders Products, Services and Solutions
Table 59. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Bristol-Myers Squibb (2019-2024)
Table 60. Bristol-Myers Squibb Recent Developments
Table 61. Teva Pharmaceutical Basic Information List
Table 62. Teva Pharmaceutical Description and Business Overview
Table 63. Teva Pharmaceutical Drugs for Treating Mental Disorders Products, Services and Solutions
Table 64. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Teva Pharmaceutical (2019-2024)
Table 65. Teva Pharmaceutical Recent Developments
Table 66. Dr. Reddy's Laboratories Basic Information List
Table 67. Dr. Reddy's Laboratories Description and Business Overview
Table 68. Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Products, Services and Solutions
Table 69. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Dr. Reddy's Laboratories (2019-2024)
Table 70. Dr. Reddy's Laboratories Recent Developments
Table 71. Apotex Inc. Basic Information List
Table 72. Apotex Inc. Description and Business Overview
Table 73. Apotex Inc. Drugs for Treating Mental Disorders Products, Services and Solutions
Table 74. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Apotex Inc. (2019-2024)
Table 75. Apotex Inc. Recent Developments
Table 76. Mylan Pharmaceuticals Basic Information List
Table 77. Mylan Pharmaceuticals Description and Business Overview
Table 78. Mylan Pharmaceuticals Drugs for Treating Mental Disorders Products, Services and Solutions
Table 79. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Mylan Pharmaceuticals (2019-2024)
Table 80. Mylan Pharmaceuticals Recent Developments
Table 81. Par Pharmaceutical Basic Information List
Table 82. Par Pharmaceutical Description and Business Overview
Table 83. Par Pharmaceutical Drugs for Treating Mental Disorders Products, Services and Solutions
Table 84. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Par Pharmaceutical (2019-2024)
Table 85. Par Pharmaceutical Recent Developments
Table 86. Aurobindo Pharma Basic Information List
Table 87. Aurobindo Pharma Description and Business Overview
Table 88. Aurobindo Pharma Drugs for Treating Mental Disorders Products, Services and Solutions
Table 89. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Aurobindo Pharma (2019-2024)
Table 90. Aurobindo Pharma Recent Developments
Table 91. Torrent Pharmaceuticals Basic Information List
Table 92. Torrent Pharmaceuticals Description and Business Overview
Table 93. Torrent Pharmaceuticals Drugs for Treating Mental Disorders Products, Services and Solutions
Table 94. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Torrent Pharmaceuticals (2019-2024)
Table 95. Torrent Pharmaceuticals Recent Developments
Table 96. Jubilant Lifesciences Basic Information List
Table 97. Jubilant Lifesciences Description and Business Overview
Table 98. Jubilant Lifesciences Drugs for Treating Mental Disorders Products, Services and Solutions
Table 99. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Jubilant Lifesciences (2019-2024)
Table 100. Jubilant Lifesciences Recent Developments
Table 101. Sun Pharmaceutical Basic Information List
Table 102. Sun Pharmaceutical Description and Business Overview
Table 103. Sun Pharmaceutical Drugs for Treating Mental Disorders Products, Services and Solutions
Table 104. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Sun Pharmaceutical (2019-2024)
Table 105. Sun Pharmaceutical Recent Developments
Table 106. Sandoz (Novartis) Basic Information List
Table 107. Sandoz (Novartis) Description and Business Overview
Table 108. Sandoz (Novartis) Drugs for Treating Mental Disorders Products, Services and Solutions
Table 109. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Sandoz (Novartis) (2019-2024)
Table 110. Sandoz (Novartis) Recent Developments
Table 111. Hansoh Pharmaceutical Basic Information List
Table 112. Hansoh Pharmaceutical Description and Business Overview
Table 113. Hansoh Pharmaceutical Drugs for Treating Mental Disorders Products, Services and Solutions
Table 114. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Hansoh Pharmaceutical (2019-2024)
Table 115. Hansoh Pharmaceutical Recent Developments
Table 116. WATSON Pharmaceuticals Basic Information List
Table 117. WATSON Pharmaceuticals Description and Business Overview
Table 118. WATSON Pharmaceuticals Drugs for Treating Mental Disorders Products, Services and Solutions
Table 119. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of WATSON Pharmaceuticals (2019-2024)
Table 120. WATSON Pharmaceuticals Recent Developments
Table 121. Zhejiang Langhua Pharmaceuticals Basic Information List
Table 122. Zhejiang Langhua Pharmaceuticals Description and Business Overview
Table 123. Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Products, Services and Solutions
Table 124. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Zhejiang Langhua Pharmaceuticals (2019-2024)
Table 125. Zhejiang Langhua Pharmaceuticals Recent Developments
Table 126. Forest Laboratories Basic Information List
Table 127. Forest Laboratories Description and Business Overview
Table 128. Forest Laboratories Drugs for Treating Mental Disorders Products, Services and Solutions
Table 129. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Forest Laboratories (2019-2024)
Table 130. Forest Laboratories Recent Developments
Table 131. H.Lundbeck A/S Basic Information List
Table 132. H.Lundbeck A/S Description and Business Overview
Table 133. H.Lundbeck A/S Drugs for Treating Mental Disorders Products, Services and Solutions
Table 134. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of H.Lundbeck A/S (2019-2024)
Table 135. H.Lundbeck A/S Recent Developments
Table 136. Amneal Pharmaceuticals Basic Information List
Table 137. Amneal Pharmaceuticals Description and Business Overview
Table 138. Amneal Pharmaceuticals Drugs for Treating Mental Disorders Products, Services and Solutions
Table 139. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Amneal Pharmaceuticals (2019-2024)
Table 140. Amneal Pharmaceuticals Recent Developments
Table 141. Hetero Drugs Basic Information List
Table 142. Hetero Drugs Description and Business Overview
Table 143. Hetero Drugs Drugs for Treating Mental Disorders Products, Services and Solutions
Table 144. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Hetero Drugs (2019-2024)
Table 145. Hetero Drugs Recent Developments
Table 146. Macleods Pharmaceuticals Basic Information List
Table 147. Macleods Pharmaceuticals Description and Business Overview
Table 148. Macleods Pharmaceuticals Drugs for Treating Mental Disorders Products, Services and Solutions
Table 149. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Macleods Pharmaceuticals (2019-2024)
Table 150. Macleods Pharmaceuticals Recent Developments
Table 151. Silarx Pharmacueticals Basic Information List
Table 152. Silarx Pharmacueticals Description and Business Overview
Table 153. Silarx Pharmacueticals Drugs for Treating Mental Disorders Products, Services and Solutions
Table 154. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Silarx Pharmacueticals (2019-2024)
Table 155. Silarx Pharmacueticals Recent Developments
Table 156. Hikma Pharmaceuticals Basic Information List
Table 157. Hikma Pharmaceuticals Description and Business Overview
Table 158. Hikma Pharmaceuticals Drugs for Treating Mental Disorders Products, Services and Solutions
Table 159. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Hikma Pharmaceuticals (2019-2024)
Table 160. Hikma Pharmaceuticals Recent Developments
Table 161. Lupin Limited Basic Information List
Table 162. Lupin Limited Description and Business Overview
Table 163. Lupin Limited Drugs for Treating Mental Disorders Products, Services and Solutions
Table 164. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Lupin Limited (2019-2024)
Table 165. Lupin Limited Recent Developments
Table 166. Prinston Pharmaceutical Basic Information List
Table 167. Prinston Pharmaceutical Description and Business Overview
Table 168. Prinston Pharmaceutical Drugs for Treating Mental Disorders Products, Services and Solutions
Table 169. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of Prinston Pharmaceutical (2019-2024)
Table 170. Prinston Pharmaceutical Recent Developments
Table 171. STI Pharma Basic Information List
Table 172. STI Pharma Description and Business Overview
Table 173. STI Pharma Drugs for Treating Mental Disorders Products, Services and Solutions
Table 174. Revenue (US$ Million) in Drugs for Treating Mental Disorders Business of STI Pharma (2019-2024)
Table 175. STI Pharma Recent Developments
Table 176. Key Raw Materials Lists
Table 177. Raw Materials Key Suppliers Lists
Table 178. Drugs for Treating Mental Disorders Downstream Customers
Table 179. Drugs for Treating Mental Disorders Distributors List
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
Table 183. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Drugs for Treating Mental Disorders Product Picture
Figure 2. Global Drugs for Treating Mental Disorders Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Drugs for Treating Mental Disorders Sales Value (2019-2030) & (US$ Million)
Figure 4. Drugs for Treating Mental Disorders Report Years Considered
Figure 5. Global Drugs for Treating Mental Disorders Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Drugs for Treating Mental Disorders Revenue in 2023
Figure 7. Drugs for Treating Mental Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Tablets Picture
Figure 9. Capsule Picture
Figure 10. Injection Picture
Figure 11. Solution Picture
Figure 12. Other Picture
Figure 13. Global Drugs for Treating Mental Disorders Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Drugs for Treating Mental Disorders Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Antipsychotics
Figure 16. Product Picture of Antidepressants
Figure 17. Product Picture of Antianxiety (Anxiolyitcs)
Figure 18. Product Picture of Anti-Seizure Medications
Figure 19. Product Picture of Stimulants
Figure 20. Product Picture of Cognitive Disorders And Dementia
Figure 21. Product Picture of Sleep Disorder Treatments
Figure 22. Product Picture of Substance Abuse Treatments
Figure 23. Product Picture of Hypnosis And Tranquilizers
Figure 24. Product Picture of Other
Figure 25. Global Drugs for Treating Mental Disorders Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Drugs for Treating Mental Disorders Sales Value Market Share by Application, 2023 & 2030
Figure 27. North America Drugs for Treating Mental Disorders Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Drugs for Treating Mental Disorders Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Drugs for Treating Mental Disorders Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Drugs for Treating Mental Disorders Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Drugs for Treating Mental Disorders Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Drugs for Treating Mental Disorders Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Drugs for Treating Mental Disorders Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Drugs for Treating Mental Disorders Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Drugs for Treating Mental Disorders Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Drugs for Treating Mental Disorders Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Drugs for Treating Mental Disorders Sales Value (%), (2019-2030)
Figure 38. United States Drugs for Treating Mental Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Drugs for Treating Mental Disorders Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Drugs for Treating Mental Disorders Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Drugs for Treating Mental Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Drugs for Treating Mental Disorders Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Drugs for Treating Mental Disorders Sales Value by Application (%), 2023 VS 2030
Figure 44. China Drugs for Treating Mental Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Drugs for Treating Mental Disorders Sales Value by Type (%), 2023 VS 2030
Figure 46. China Drugs for Treating Mental Disorders Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Drugs for Treating Mental Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Drugs for Treating Mental Disorders Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Drugs for Treating Mental Disorders Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Drugs for Treating Mental Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Drugs for Treating Mental Disorders Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Drugs for Treating Mental Disorders Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Drugs for Treating Mental Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Drugs for Treating Mental Disorders Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Drugs for Treating Mental Disorders Sales Value by Application (%), 2023 VS 2030
Figure 56. India Drugs for Treating Mental Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Drugs for Treating Mental Disorders Sales Value by Type (%), 2023 VS 2030
Figure 58. India Drugs for Treating Mental Disorders Sales Value by Application (%), 2023 VS 2030
Figure 59. Drugs for Treating Mental Disorders Industrial Chain
Figure 60. Drugs for Treating Mental Disorders Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
